tiprankstipranks
Everest Medicines Ltd. (HK:1952)
HKEX:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

1952 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Everest
Medicines Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1952 Stock 12 Months Forecast

There Are No Analyst Ratings for HK:1952 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1952 Financial Forecast

1952 Earnings Forecast

Next quarter’s earnings estimate for 1952 is -HK$1.89 with a range of -HK$1.89 to -HK$1.89. The previous quarter’s EPS was -HK$1.52. 1952 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 49.71% of the time in the same period. In the last calendar year 1952 has Outperformed its overall industry.
Next quarter’s earnings estimate for 1952 is -HK$1.89 with a range of -HK$1.89 to -HK$1.89. The previous quarter’s EPS was -HK$1.52. 1952 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 49.71% of the time in the same period. In the last calendar year 1952 has Outperformed its overall industry.

1952 Sales Forecast

Next quarter’s sales forecast for 1952 is HK$125.88M with a range of HK$125.88M to HK$125.88M. The previous quarter’s sales results were HK$10.06M. 1952 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 56.86% of the time in the same period. In the last calendar year 1952 has Underperformed its overall industry.
Next quarter’s sales forecast for 1952 is HK$125.88M with a range of HK$125.88M to HK$125.88M. The previous quarter’s sales results were HK$10.06M. 1952 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 56.86% of the time in the same period. In the last calendar year 1952 has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
HK$18.66
Hold
-22.73%
Downside
Reiterated
11/26/23
Everest Medicines Ltd (1952:HK) PT Raised to HK$18.66 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on Everest Medicines Ltd (1952:HK) to HK$18.66 (from HK$18.28) while maintaining a Neutral rating.
H.C. Wainwright
HK$35.00
Buy
44.93%
Upside
Reiterated
04/03/23
We maintain our Buy rating of 1952.HK and raise our 12-month price target to HK$35 per share, from HK$27 per share. We derive our price target based on a risk-adjusted net present value (rNPV) analysis of projected future revenues from Everest Medicines’ product candidates in China, assuming an 12% discount rate and a 0% terminal growth rate. We derive a rNPV of RMB7.8B for the products and add in pro forma net cash and cash equivalents of RMB3.0B, to arrive at a 12-month price target of HK$33.69 per diluted share, which we round to HK$35.
Citi Analyst forecast on HK:1952
Unknown Analyst
Not Ranked
Citi
HK$27.00
Hold
11.80%
Upside
Reiterated
11/27/23
Everest Medicines Ltd (1952:HK) PT Raised to HK$27 at CitiCiti raised its price target on Everest Medicines Ltd (1952:HK) to HK$27.00 (from HK$18.60) while maintaining a Neutral rating.

Best Analysts Covering Everest Medicines Ltd.

Which Analyst Should I Follow If I Want to Buy HK:1952 and Sell After:
1 Month
Arthur He CFAH.C. Wainwright
Success Rate
1/3 ratings generated profit
33%
Average Return
+17.13%
reiterated a buy rating 11 months ago
Copying Arthur He CFA's trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +17.13% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Arthur He CFAH.C. Wainwright
Success Rate
2/3 ratings generated profit
67%
Average Return
+93.30%
reiterated a buy rating 11 months ago
Copying Arthur He CFA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +93.30% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Arthur He CFAH.C. Wainwright
Success Rate
3/3 ratings generated profit
100%
Average Return
+120.93%
reiterated a buy rating 11 months ago
Copying Arthur He CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +120.93% per trade.
2 Years
Arthur He CFAH.C. Wainwright
Success Rate
3/3 ratings generated profit
100%
Average Return
+124.13%
reiterated a buy rating 11 months ago
Copying Arthur He CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +124.13% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1952 Analyst Recommendation Trends

Rating
Mar 23
Apr 23
Aug 23
Sep 23
Nov 23
Strong Buy
2
2
2
1
0
Buy
0
0
0
0
0
Hold
2
3
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
5
4
3
In the current month, 1952 has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 1952 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1952 Stock Forecast FAQ

What is HK:1952’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1952’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1952, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Everest Medicines Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Everest Medicines Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Everest Medicines Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Everest Medicines Ltd.?
      To buy shares of HK:1952, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis